The DPP-4 Inhibitor Linagliptin Improves Cardiac Function in GLP-1 Receptor Knockout Mice with Hypertrophic Heart Failure

被引:0
|
作者
Batchu, Sri N.
Kabir, Golam
Klein, Thomas
Connelly, Kim A.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
485-P
引用
收藏
页码:A127 / A127
页数:1
相关论文
共 50 条
  • [41] Non-GLP-1 Peptide Substrates of DPP-4 Improve Cardiac Function in Young Mice but Not Obese Diabetic Mice
    Batchu, Sri N.
    Kabir, Golam
    Klein, Thomas
    Connelly, Kim A.
    Advani, Andrew
    DIABETES, 2017, 66 : A52 - A52
  • [42] Differential importance of GIP vs. GLP-1 receptor signalling vs. DPP-4 inhibition for beta cell survival and function in mice
    Maida, A.
    Seino, Y.
    Drucker, D. J.
    DIABETOLOGIA, 2008, 51 : S363 - S364
  • [43] Inhibition of DPP-4 augments insulin secretion in response to GLP-1, GIP, PACAP and GRP in mice
    Ahrén, B
    Hughes, TE
    DIABETES, 2004, 53 : A339 - A339
  • [44] Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
    Aroda, Vanita R.
    Henry, Robert R.
    Han, Jenny
    Huang, Wenying
    DeYoung, Mary Beth
    Darsow, Tamara
    Hoogwerf, Byron J.
    CLINICAL THERAPEUTICS, 2012, 34 (06) : 1247 - 1258
  • [45] GLP-1 receptor agonists in heart failure
    Vaduganathan, Muthiah
    LANCET, 2024, 404 (10454): : 727 - 729
  • [46] Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors
    Neumiller, Joshua J.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 : S16 - S29
  • [47] From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy
    Dicembrini, Ilaria
    Pala, Laura
    Rotella, Carlo Maria
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [48] High DPP-4 Concentrations in Adolescents Are Associated With Low Intact GLP-1
    Stenlid, Rasmus
    Manell, Hannes
    Halldin, Maria
    Kullberg, Joel
    Ahlstrom, Hakan
    Manukyan, Levon
    Weghuber, Daniel
    Paulmichl, Katharina
    Zsoldos, Fanni
    Bergsten, Peter
    Forslund, Anders
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (08): : 2958 - 2966
  • [49] GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
    Xu, Yang
    Fu, Edouard L.
    Clase, Catherine M.
    Mazhar, Faizan
    Jardine, Meg J.
    Carrero, Juan J.
    KIDNEY INTERNATIONAL, 2022, 101 (02) : 360 - 368
  • [50] Predictors of efficacy of GLP-1 agonists and DPP-4 inhibitors: A systematic review
    Bihan, Helene
    Ng, Winda L.
    Magliano, Dianna J.
    Shaw, Jonathan E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 121 : 27 - 34